Drug Pricing

The Supreme Court questioned steep hospital mark-ups on cancer medicines and medical consumables, criticised the Centre's pricing framework and reserved its verdict on a plea seeking tighter controls

Updated On: 27 Oct 2026 | 9:05 PM IST

Drug regulators in Maharashtra, Karnataka and Uttar Pradesh are gathering data on price mark-ups, potentially strengthening the case for a review of trade margin rationalisation

Updated On: 06 Oct 2026 | 6:24 PM IST

A Bench of Justices Vikram Nath and Sandeep Mehta asked the Centre why the maximum retail price (MRP) of essential medicines such as cancer drugs could not be capped at 16 per cent

Updated On: 29 Sep 2026 | 10:33 PM IST

India's pharma sector remains resilient despite West Asia disruptions, as the government advances biopharma, R&D and bulk drug manufacturing initiatives

Updated On: 08 Jun 2026 | 12:01 AM IST

White House economists estimate that President Donald Trump's deals with pharmaceutical companies to drop some of their US prescription drug prices to what they charge in other countries could save USD 529 billion over the next 10 years. The analysis obtained by The Associated Press includes the first economy-wide projections behind a policy at the core of Trump's pitch to voters going into November's midterm elections for control of the House and Senate. Democratic lawmakers have been doubtful about the savings claimed by Trump and these new numbers are likely to trigger additional questions about the data. Cost-of-living issues are at the forefront of voters' concerns and higher energy prices tied to the Iran war have deepened the public's anxiety. Trump has tried in part to address affordability concerns by focusing on his efforts to cut deals with companies so that the cost of prescription drugs in the US would no longer be dramatically higher than in other affluent nations. "

Updated On: 05 May 2026 | 9:15 PM IST

Eli Lilly CEO Dave Ricks slammed the UK's strict drug pricing rules, warning that the country risks losing new medicines and investment unless changes are made to its rebate scheme

Updated On: 24 Sep 2025 | 4:24 PM IST

The formulations in the new revised rate list include essential drugs such as painkillers, antivirals, antibiotics, antimalarials, and drugs for type 2 diabetes

Updated On: 31 Mar 2024 | 5:58 PM IST

The company reported a consolidated profit of Rs 35,600 crore ($42.9 million) for the first quarter ended June 30, compared to Rs 702 crore a year ago

Updated On: 14 Aug 2023 | 2:35 PM IST

The Centre has been mulling on rationalizing drug trade margins for a while now for widely used medicines in an effort to bring down prices

Updated On: 09 May 2023 | 8:15 PM IST

Competitive pricing among firms keeps rates at Rs 1,400-2,490 for full treatment

Updated On: 05 Jan 2022 | 6:10 AM IST

Despite the muted result and near term worries, the multinational drug major, India's second largest by market share is expected to post strong growth led by power brands and new launches

Updated On: 11 Jun 2020 | 12:53 PM IST

Price caps on drugs should be weighed carefully

Updated On: 21 May 2019 | 11:50 PM IST

Pharma companies feat the move might hit their pricing strategies and put local firms in a disadvantageous position

Updated On: 10 Oct 2017 | 12:35 PM IST

For around 140 medicines in the list of essential medicines, the NPPA does not have market data

Updated On: 15 Jan 2017 | 10:30 AM IST

Earlier govt added 106 and removed 70 medicines from earlier one of 2011 expanding the list to 376 from 348

Updated On: 15 Mar 2016 | 12:02 AM IST